You are here

Home
Export 196 results:
Filters: First Letter Of Last Name is S  [Clear All Filters]
A
Kenawy, H. Ibrahim, Ali Y. Mohammed, Rajakumar K., Lynch N. J., Kadioglu A., Stover C. M., et al. (2012).  Absence of the lectin activation pathway of complement does not increase susceptibility to Pseudomonas aeruginosa infections. Immunobiology. 217, 272–280.
Kenawy, H. Ibrahim, Ali Y. Mohammed, Rajakumar K., Lynch N. J., Kadioglu A., Stover C. M., et al. (2012).  Absence of the lectin activation pathway of complement does not increase susceptibility to Pseudomonas aeruginosa infections. Immunobiology. 217, 272–280.
Spickard, A.., Evans H.., Knight V.., & Johnson K.. (1963).  ACUTE RESPIRATORY DISEASE IN NORMAL VOLUNTEERS ASSOCIATED WITH COXSACKIE A-21 VIRAL INFECTION. III. RESPONSE TO NASOPHARYNGEAL AND ENTERIC INOCULATION. Journal of Clinical Investigation. 42, 6.
Saslaw, S.., & Carlisle H.. N. (1966).  Aerosol Infection of Monkeys with Rickettsia Rickettsi. Bacteriological Reviews. 30, 636-644.
Saslaw, S., & Carlisle H. N. (1966).  Aerosol infection of monkeys with Rickettsia rickettsii. Bacteriological Reviews. 30, 3.
Czuprynski, C. J., Faith N. G., & Steinberg H. (2003).  A/J Mice Are Susceptible and C57BL/6 Mice Are Resistant to Listeria monocytogenes. Infection and Immunity. 71, 2.
SL, Jr, S. (2003).  Amoebiasis. Lancet. 2361,
Scott, G., Williams J. C., & Stephenson E. H. (1987).  Animal models in Q fever: pathological responses of inbred mice to phase I Coxiella Burnetii. Journal of General Microbiology. 133, 691-700.
Scott, G., Williams J. C., & Stephenson E. H. (1987).  Animal models in Q fever: pathological responses of inbred mice to phase I Coxiella Burnetii. Journal of General Microbiology. 133, 691-700.
Scott, G.. H., Williams J.. C., & Stephenson E.. H. (1987).  Animal Models in Q Fever: Pathological Responses of Inbred Mice to Phase I Coxiella burnetii. Journal of General Microbiology. 133, 3.
Scott, G.. H., Williams J.. C., & Stephenson E.. H. (1987).  Animal Models in Q Fever: Pathological Responses of Inbred Mice to Phase I Coxiella burnetii. Journal of General Microbiology. 133, 3.
Shepard, C.. W., Soriano-Gabarro M.., Zell E.. R., Hayslett J.., Lukacs S.., Goldstein S.., et al. (2002).  Antimicrobial postexposure prophylaxis for anthrax: adverse events and adherence. Emerging infectious diseases. 8, 10.
Shepard, C.. W., Soriano-Gabarro M.., Zell E.. R., Hayslett J.., Lukacs S.., Goldstein S.., et al. (2002).  Antimicrobial postexposure prophylaxis for anthrax: adverse events and adherence. Emerging infectious diseases. 8, 10.
Lamparelli, C. Condé, Pogreba-Brown K., Verhougstraete M., Sato M. Inês Zano, Bruni A. de Castro, Wade T. J., et al. (2015).  Are fecal indicator bacteria appropriate measures of recreational water risks in the tropics: a cohort study of beach goers in Brazil?. Water research. 87, 59–68.
Sidhu, JPS., & Toze S. (2012).  Assessment of pathogen survival potential during managed aquifer recharge with diffusion chambers. Journal of applied microbiology. 113, 693–700.
Tribble, D. R., Baqar S., Scott D. A., Oplinger M. L., Trespalacios F., Rollins D., et al. (2010).  Assessment of the Duration of Protection in Campylobacter jejuni Experimental Infection in Humans. Infection and Immunity. 78, 4.
B
Sabin, A. B. (1955).  Behavior of chimpanzee avirulent poliomyelitis viruses in experimentally infected human volunteers. The American journal of the medical sciences. 230, 1.
Sabin, A.. B. (1955).  Behaviour Of Chimpanzee-Avirulent Poliomyelitis Viruses In Experimentally Infected Human Volunteers. The British Medical Journal. 2, 160-162.
Gurian, P.. L., Small M.. J., Lockwood J.. R., & Schervish M.. J. (2001).  Benefit-cost estimation for alternative drinking water maximum contaminant levels. Water Resources Research. 37, 8.
Gurian, P.. L., Small M.. J., Lockwood J.. R., & Schervish M.. J. (2001).  Benefit-cost estimation for alternative drinking water maximum contaminant levels. Water Resources Research. 37, 8.
Jernigan, J.. A., Stephens D.. S., Ashford D.. A., Omenaca C.., Topiel M.. S. >, Galbraith M.., et al. (2001).  Bioterrorism Related Inhalational Anthrax: The First 10 Cases Reported in the United States. Emerging Infectious Diseases. 7, 933-944.
Jernigan, J.. A., Stephens D.. S., Ashford D.. A., Omenaca C.., Topiel M.. S. >, Galbraith M.., et al. (2001).  Bioterrorism Related Inhalational Anthrax: The First 10 Cases Reported in the United States. Emerging Infectious Diseases. 7, 933-944.
Jernigan, J.. A., Stephens D.. S., Ashford D.. A., Omenaca C.., Topiel M.. S. >, Galbraith M.., et al. (2001).  Bioterrorism Related Inhalational Anthrax: The First 10 Cases Reported in the United States. Emerging Infectious Diseases. 7, 933-944.
Jernigan, J.. A., Stephens D.. S., Ashford D.. A., Omenaca C.., Topiel M.. S. >, Galbraith M.., et al. (2001).  Bioterrorism Related Inhalational Anthrax: The First 10 Cases Reported in the United States. Emerging Infectious Diseases. 7, 933-944.
Jernigan, J. A., Stephens D. S., Ashford D. A., Omenaca C., Topiel M. S., Galbraith M., et al. (2001).  Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States.. Emerging infectious diseases. 7, 933.